Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA NATCO PHARMA GSK PHARMA/
NATCO PHARMA
 
P/E (TTM) x 62.2 13.3 466.6% View Chart
P/BV x 18.9 3.5 540.1% View Chart
Dividend Yield % 1.6 0.6 284.9%  

Financials

 GSK PHARMA   NATCO PHARMA
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
NATCO PHARMA
Mar-23
GSK PHARMA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,684847 198.9%   
Low Rs1,231502 245.2%   
Sales per share (Unadj.) Rs191.9148.4 129.4%  
Earnings per share (Unadj.) Rs35.939.2 91.5%  
Cash flow per share (Unadj.) Rs39.848.2 82.5%  
Dividends per share (Unadj.) Rs32.005.50 581.8%  
Avg Dividend yield %2.20.8 269.2%  
Book value per share (Unadj.) Rs102.9267.1 38.5%  
Shares outstanding (eoy) m169.41182.47 92.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.64.5 167.0%   
Avg P/E ratio x40.617.2 236.2%  
P/CF ratio (eoy) x36.714.0 261.9%  
Price / Book Value ratio x14.22.5 561.0%  
Dividend payout %89.214.0 635.9%   
Avg Mkt Cap Rs m246,858123,049 200.6%   
No. of employees `000NANA-   
Total wages/salary Rs m5,9504,867 122.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,51727,071 120.1%  
Other income Rs m1,0071,285 78.3%   
Total revenues Rs m33,52428,356 118.2%   
Gross profit Rs m8,0339,117 88.1%  
Depreciation Rs m6581,638 40.2%   
Interest Rs m18145 12.5%   
Profit before tax Rs m8,3648,619 97.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2881,466 156.0%   
Profit after tax Rs m6,0767,153 84.9%  
Gross profit margin %24.733.7 73.4%  
Effective tax rate %27.417.0 160.8%   
Net profit margin %18.726.4 70.7%  
BALANCE SHEET DATA
Current assets Rs m24,94330,003 83.1%   
Current liabilities Rs m13,2646,831 194.2%   
Net working cap to sales %35.985.6 42.0%  
Current ratio x1.94.4 42.8%  
Inventory Days Days9763 153.2%  
Debtors Days Days216115 187.1%  
Net fixed assets Rs m6,98826,571 26.3%   
Share capital Rs m1,694365 464.1%   
"Free" reserves Rs m15,73548,373 32.5%   
Net worth Rs m17,43048,738 35.8%   
Long term debt Rs m00-   
Total assets Rs m31,93056,574 56.4%  
Interest coverage x462.660.4 765.4%   
Debt to equity ratio x00-  
Sales to assets ratio x1.00.5 212.8%   
Return on assets %19.112.9 148.0%  
Return on equity %34.914.7 237.5%  
Return on capital %48.118.0 267.4%  
Exports to sales %00-   
Imports to sales %48.110.2 469.4%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m15,6302,772 563.9%   
Fx inflow Rs m1,62217,256 9.4%   
Fx outflow Rs m15,6302,772 563.9%   
Net fx Rs m-14,00814,484 -96.7%   
CASH FLOW
From Operations Rs m4,8428,491 57.0%  
From Investments Rs m8,079-4,771 -169.3%  
From Financial Activity Rs m-15,433-3,630 425.2%  
Net Cashflow Rs m-2,512208 -1,207.9%  

Share Holding

Indian Promoters % 0.0 49.7 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 11.6 25.0 46.4%  
FIIs % 2.9 13.7 21.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 50.3 49.7%  
Shareholders   114,663 207,571 55.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GSK Pharma vs Natco Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GSK Pharma vs Natco Pharma Share Price Performance

Period GSK Pharma Natco Pharma S&P BSE HEALTHCARE
1-Day 3.26% -2.11% 1.18%
1-Month -9.77% -3.19% -0.75%
1-Year 52.63% 72.80% 61.82%
3-Year CAGR 10.89% 4.96% 18.16%
5-Year CAGR 8.44% 10.96% 19.79%

* Compound Annual Growth Rate

Here are more details on the GSK Pharma share price and the Natco Pharma share price.

Moving on to shareholding structures...

The promoters of GSK Pharma hold a 75.0% stake in the company. In case of Natco Pharma the stake stands at 49.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GSK Pharma and the shareholding pattern of Natco Pharma.

Finally, a word on dividends...

In the most recent financial year, GSK Pharma paid a dividend of Rs 32.0 per share. This amounted to a Dividend Payout ratio of 89.2%.

Natco Pharma paid Rs 5.5, and its dividend payout ratio stood at 14.0%.

You may visit here to review the dividend history of GSK Pharma, and the dividend history of Natco Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.